Skip to main content

Advertisement

Log in

Gender differences in colorectal cancer survival in Japan

  • Original Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

An Erratum to this article was published on 13 August 2015

Abstract

Background

A gender difference in survival has been documented in colorectal cancer (CRC) patients, although the underlying mechanism remains undefined. This study aimed to gain improved insight into this difference, with a special focus on improved cancer-specific survival.

Methods

The study population consisted of 82,402 patients with invasive CRC who had undergone surgery in Japan between 1985 and 2004. To estimate improved survival, multivariate adjustment using patient demographics and tumor characteristics was performed.

Results

Patient characteristics changed over time. The 5-year survival rates increased from 66.5 to 76.3 % during the study period. Higher survival rates persisted in women over time (multivariate-adjustment model—hazard ratio [HR] 0.87, 95 % confidence interval [CI] 0.85–0.90). Patients who received surgery during the period 2000–2004 had significantly longer survival than those during the period 1985–1989 (men: HR 0.70, 95 % CI 0.67–0.74; women: HR 0.72, 95 % CI 0.67–0.76). However, there was no gender difference regarding improved survival.

Conclusions

A reduced risk of cancer-specific death for women relative to men persisted over time; however, enhancement of survival was equally observed in both genders. Identification of factors associated with gender differences and changes over time in CRC survival may serve as targets for further improvement.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Ferlay J, Soerjomataram I, Ervik M et al (2013) GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer. http://globocan.iarc.fr. Accessed on 27 Apr 2015

  2. Gao RN, Neutel CI, Wai E (2008) Gender differences in colorectal cancer incidence, mortality, hospitalizations and surgical procedures in Canada. J Public Health (Oxf) 30(2):194–201

    Article  Google Scholar 

  3. Cheng X, Chen VW, Steele B et al (2001) Subsite-specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the United States, 1992–1997. Cancer 92(10):2547–2554

    Article  CAS  PubMed  Google Scholar 

  4. Allemani C, Weir HK, Carreira H, CONCORD Working Group et al (2015) Global surveillance of cancer survival 1995–2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 385(9972):977–1010

    Article  PubMed  Google Scholar 

  5. Zeng C, Wen W, Morgans A et al (2015) Disparities by race, age, and sex in the improvement of survival for major cancers: results from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010. JAMA Oncol 1(1):88–96

    Article  PubMed  Google Scholar 

  6. Matsuda T, Ajiki W, Marugame T et al, Research Group of Population-Based Cancer Registries of Japan: monitoring of Cancer Incidence in Japan—Survival 2003–2005 Report (Center for Cancer Control and Information Services, National Cancer Center, 2013) (2011) Population-based survival of cancer patients diagnosed between 1993 and 1999 in Japan: a chronological and international comparative study. Jpn J Clin Oncol 41:40–51

    Article  PubMed  Google Scholar 

  7. André T, Boni C, Mounedji-Boudiaf L et al (2004) Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) Investigators: oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350(23):2343–2351

    Article  PubMed  Google Scholar 

  8. Kopetz S, Chang GJ, Overman MJ et al (2009) Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 27(22):3677–3683

    Article  PubMed Central  PubMed  Google Scholar 

  9. Matsuda A, Matsuda T, Shibata A et al (2013) Cancer Incidence and Incidence Rates in Japan in 2008: a Study of 25 Population-based Cancer Registries for the Monitoring of Cancer Incidence in Japan (MCIJ) Project. Jpn J Clin Oncol 44(4):388–396

    Article  Google Scholar 

  10. Ministry of Health, Labour and Welfare (2015) Vital Statistics Japan. http://www.mhlw.go.jp/english/database/db-hw/index.html. Accessed on 27 Apr 2015

  11. Kotake K, Honjo S, Sugihara K et al (2003) Changes in colorectal cancer during a 20-year period: an extended report from the multi-institutional registry of large bowel cancer, Japan. Dis Colon Rectum 46(10 Suppl):S32–S43

    PubMed  Google Scholar 

  12. Rhodes JB, Holmes FF, Clark GM (1997) Changing distribution of primary cancers in the large bowel. JAMA 238(15):1641–1643

    Article  Google Scholar 

  13. Ji BT, Devesa SS, Chow WH et al (1998) Colorectal cancer incidence trends by subsite in urban Shanghai, 1972–1994. Cancer Epidemiol Biomark Prev 7(8):661–666

    CAS  Google Scholar 

  14. Wichmann MW, Müller C, Hornung HM et al (2001) Gender differences in long-term survival of patients with colorectal cancer. Br J Surg 88(8):1092–1098

    Article  CAS  PubMed  Google Scholar 

  15. McArdle CS, McMillan DC, Hole DJ (2003) Male gender adversely affects survival following surgery for colorectal cancer. Br J Surg 90(6):711–715

    Article  CAS  PubMed  Google Scholar 

  16. Paulson EC, Wirtalla C, Armstrong K et al (2009) Gender influences treatment and survival in colorectal cancer surgery. Dis Colon Rectum 52(12):1982–1991

    Article  PubMed  Google Scholar 

  17. Siegel R, DeSantis C (2014) Colorectal cancer statistics, 2014. CA Cancer J Clin 64(2):104–117

    Article  PubMed  Google Scholar 

  18. Verschueren RC, Mulder NH, Van Loon AJ et al (1997) The anatomical substrate for a differences in surgical approach to rectal cancer in male and female patients. Anticancer Res 17(1B):637–641

    CAS  PubMed  Google Scholar 

  19. Fietkau R, Rödel C, Hohenberger W et al (2007) Rectal cancer delivery of radiotherapy in adequate time and with adequate dose is influenced by treatment center, treatment schedule, and gender and is prognostic parameter for local control: results of study CAO/ARO/AIO-94. Int J Radiat Oncol Biol Phys 67(4):1008–1019

    Article  PubMed  Google Scholar 

  20. Slattery ML, Friedman GD, Potter JD et al (1996) A description of age, sex, and site distributions of colon carcinoma in three geographic areas. Cancer 78(8):1666–1670

    Article  CAS  PubMed  Google Scholar 

  21. Hendifar A, Yang D, Lenz F et al (2009) Gender disparities in metastatic colorectal cancer survival. Clin Cancer Res 15(20):6391–6397

    Article  PubMed Central  PubMed  Google Scholar 

  22. McMillan DC, Wotherspoon HA, Fearon KC et al (1995) A prospective study of tumor recurrence and the acute-phase response after apparently cur active colorectal cancer surgery. Am J Surg 170(4):319–322

    Article  CAS  PubMed  Google Scholar 

  23. Ward R, Meagher A, Tomlinson I et al (2001) Microsatellite instability and the clinicopathological features of sporadic colorectal cancer. Gut 48(6):821–829

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  24. Hawkins N, Norrie M, Cheong K et al (2002) CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology 122(5):1376–1387

    Article  CAS  PubMed  Google Scholar 

  25. Ogino S, Cantor M, Kawasaki T et al (2006) CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies. Gut 55(7):1000–1006

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  26. Martling A, Granath F, Cedermark B et al (2009) Gender differences in the treatment of rectal cancer: a population based study. Eur J Surg Oncol 35(4):427–433

    Article  CAS  PubMed  Google Scholar 

  27. Rayson D, Urquhart R, Cox M et al (2012) Adherence to clinical practice guidelines for adjuvant chemotherapy for colorectal cancer in a Canadian province: a population-based analysis. J Oncol Pract 8(4):253–259

    Article  PubMed Central  PubMed  Google Scholar 

  28. Jessup JM, Stewart A, Greene FL et al (2005) Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. JAMA 294(21):2703–2711

    Article  CAS  PubMed  Google Scholar 

  29. Verschueren RC, Mulder NH, Van Loon AJ et al (1997) The anatomical substrate for a differences in surgical approach to rectal cancer in male and female patients. Anticancer Res 17(1B):637–641

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported in part by the National Cancer Center Research and Development Fund (26-A-32).

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kenjiro Kotake.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (XLSX 11 kb)

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kotake, K., Asano, M., Ozawa, H. et al. Gender differences in colorectal cancer survival in Japan. Int J Clin Oncol 21, 194–203 (2016). https://doi.org/10.1007/s10147-015-0868-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-015-0868-6

Keywords

Navigation